Sharon E. Parker

564 total citations
17 papers, 469 citations indexed

About

Sharon E. Parker is a scholar working on Applied Microbiology and Biotechnology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sharon E. Parker has authored 17 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Applied Microbiology and Biotechnology, 4 papers in Pharmacology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sharon E. Parker's work include Antibiotic Use and Resistance (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Pharmaceutical studies and practices (4 papers). Sharon E. Parker is often cited by papers focused on Antibiotic Use and Resistance (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Pharmaceutical studies and practices (4 papers). Sharon E. Parker collaborates with scholars based in United Kingdom and United States. Sharon E. Parker's co-authors include Peter Davey, Gary D. Kao, Geoffrey A. Geiger, Jennifer Tucker, Mary C. Mullins, Melissa L. Dowling, Fang Liu, Kathleen M. Murphy, Mijin Kim and Mijin Kim and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Journal of Bone and Joint Surgery.

In The Last Decade

Sharon E. Parker

17 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon E. Parker United Kingdom	12	126	117	89	77	77	17	469
Joan Antoni Schoenenberger-Arnaiz Spain	13	141 1.1×	45 0.4×	146 1.6×	21 0.3×	24 0.3×	33	485
Sarah Bourne United Kingdom	9	139 1.1×	32 0.3×	44 0.5×	7 0.1×	68 0.9×	17	349
Lai Wei China	15	168 1.3×	17 0.1×	207 2.3×	9 0.1×	42 0.5×	53	653
M A Romeo Italy	11	41 0.3×	17 0.1×	71 0.8×	14 0.2×	14 0.2×	21	801
Ali Bazı Iran	12	106 0.8×	33 0.3×	52 0.6×	6 0.1×	18 0.2×	73	429
Stacy J. Childs United States	16	86 0.7×	106 0.9×	354 4.0×	11 0.1×	21 0.3×	50	1.0k
Seung Hee Lee South Korea	16	274 2.2×	57 0.5×	59 0.7×	13 0.2×	21 0.3×	46	636
Imran Iqbal Pakistan	14	48 0.4×	37 0.3×	155 1.7×	16 0.2×	8 0.1×	33	558
Troy J. Plumb United States	14	171 1.4×	60 0.5×	62 0.7×	7 0.1×	9 0.1×	36	802
Alan T. Davis United States	12	165 1.3×	31 0.3×	127 1.4×	15 0.2×	4 0.1×	21	521

Countries citing papers authored by Sharon E. Parker

Since Specialization

Citations

This map shows the geographic impact of Sharon E. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon E. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon E. Parker more than expected).

Fields of papers citing papers by Sharon E. Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon E. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon E. Parker. The network helps show where Sharon E. Parker may publish in the future.

Co-authorship network of co-authors of Sharon E. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon E. Parker. A scholar is included among the top collaborators of Sharon E. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon E. Parker. Sharon E. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Byrd, J. W. Thomas, et al.. (2019). The Safety of Hip Arthroscopy within 3 Months of an Intra-Articular Injection. Journal of Bone and Joint Surgery. 101(16). 1467–1469. 9 indexed citations

Flemming, A. F. S., et al.. (2015). Multidisciplinary team briefings: A way forward. UWA Profiles and Research Repository (University of Western Australia). 14(2). 12–14. 4 indexed citations

King, David, et al.. (2015). Service Evaluation of Headucate’s Educational Intervention to Reduce Stigma and Increase Mental Health Literacy Among School Children. European Psychiatry. 30. 1212–1212. 1 indexed citations

Wise, Marilyn, et al.. (2013). National Appraisal of Continuous Quality Improvement Initiatives in Aboriginal and Torres Strait Islander Primary Health Care : Final report March 2013. 6 indexed citations

Kim, Mijin, Melissa L. Dowling, Khinh Ranh Voong, et al.. (2008). TRAIL Inactivates the Mitotic Checkpoint and Potentiates Death Induced by Microtubule-Targeting Agents in Human Cancer Cells. Cancer Research. 68(9). 3440–3449. 38 indexed citations

Geiger, Geoffrey A., et al.. (2006). Zebrafish as a “Biosensor”? Effects of Ionizing Radiation and Amifostine on Embryonic Viability and Development. Cancer Research. 66(16). 8172–8181. 90 indexed citations

Kim, Mijin, Kathleen M. Murphy, Fang Liu, et al.. (2005). Caspase-Mediated Specific Cleavage of BubR1 Is a Determinant of Mitotic Progression. Molecular and Cellular Biology. 25(21). 9232–9248. 54 indexed citations

Parker, Sharon E., et al.. (1998). Evaluation of the impact of non-inpatient i.v. antibiotic treatment for acute infections on the hospital, primary care services and the patient.. Journal of Antimicrobial Chemotherapy. 42(3). 373–380. 26 indexed citations

Davey, Peter, et al.. (1995). Prospective audit of costs and outcome of aminoglycoside treatment and of therapy for Gram-negative bacteraemia. Journal of Antimicrobial Chemotherapy. 36(3). 561–575. 14 indexed citations

10.

Davey, Peter, Sharon E. Parker, Iain K. Crombie, & Magnus Jäderberg. (1995). The Cost Effectiveness of Amoxicillin/Clavulanic Acid as Antibacterial Prophylaxis in Abdominal and Gynaecological Surgery. PharmacoEconomics. 7(4). 347–356. 12 indexed citations

11.

Parker, Sharon E. & Peter Davey. (1995). Once-Daily Aminoglycoside Administration in Gram-Negative Sepsis. PharmacoEconomics. 7(5). 393–402. 15 indexed citations

12.

Davey, Peter, et al.. (1994). Assessing cost effectiveness of antimicrobial treatment: monotherapy compared with combination therapy.. PubMed. 67–72. 14 indexed citations

13.

Parker, Sharon E. & Peter Davey. (1993). Practicalities of once-daily aminoglycoside dosing. Journal of Antimicrobial Chemotherapy. 31(1). 4–8. 45 indexed citations

14.

Davey, Peter, et al.. (1993). Pharmacoeconomics of antimicrobial prophylaxis. Journal of Antimicrobial Chemotherapy. 31(suppl B). 107–118. 7 indexed citations

15.

Parker, Sharon E. & Peter Davey. (1992). Pharmacoeconomics of Intravenous Drug Administration. PharmacoEconomics. 1(2). 103–115. 67 indexed citations

16.

Davey, Peter & Sharon E. Parker. (1992). Cost Effectiveness of Once‐Daily Oral Antimicrobial Therapy. The Journal of Clinical Pharmacology. 32(8). 706–710. 25 indexed citations

17.

Davey, Peter, et al.. (1992). Pharmacoeconomics of Antibacterial Treatment. PharmacoEconomics. 1(6). 409–437. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact